One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations
Chang Liu, MPH; Devinder Dhindsa, MD; Zakaria Almuwaqqat, MD, MPH; Yi-An Ko, PhD; Anurag Mehta, MD;Ayman A. Alkhoder, MD; Zahran Alras, MD; Shivang Rajan Desai, MD; Krishan Jignesh Patel, MD;Ananya Hooda, MBBS; Mohamad Wehbe, BS; Laurence S. Sperling, MD; Yan V. Sun, PhD; Arshed A. Quyyumi, MD
doi : 10.1001/jamacardio.2022.0912
July 2022, Vol 7, No. 7, Pages 662-776
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior StrokeA Post Hoc Analysis From the AUGUSTUS Trial
M. Cecilia Bahit, MD; Amit N. Vora, MD, MPH; Zhuokai Li, PhD; Daniel M. Wojdyla, MS; Laine Thomas, PhD;Shaun G. Goodman, MD, MSc; Ronald Aronson, MD; J. Dedrick Jordan, MD, PhD; Brad J. Kolls, MD, PhD;Keith E. Dombrowski, MD; Dragos Vinereanu, MD, PhD; Sigrun Halvorsen, MD, PhD; Otavio Berwanger, MD, PhD;Stephan Windecker, MD; Roxana Mehran, MD; Christopher B. Granger, MD; John H. Alexander, MD, MHS;Renato D. Lopes, MD, MHS, PhD
Management of Acute Coronary Syndromes in Patients in Rural AustraliaThe MORACS Randomized Clinical Trial
Fiona Dee, RN; Lindsay Savage, RN; James W. Leitch, MBBS; Nicholas Collins, MBBS, MD; Conrad Loten, MBBS;Peter Fletcher, MBBS, PhD; John French, BMedSc, MBChB, MSc, PhD; Natasha Weaver, BMath, PhD;Olivia Watson, RN; Helen Orvad, RN; Kerry J. Inder, RN, PhD; Dawn McIvor, RN; Trent Williams, RN, PhD;Allan J. Davies, MBBS, MPH; John Attia, MD; John Wiggers, MD; Aaron L. Sverdlov, MBBS, PhD;Andrew J. Boyle, MBBS, PhD
Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac ArrestResults of the Randomized, Multicentric EMERGE Trial
Caroline Hauw-Berlemont, MD, MS; Lionel Lamhaut, MD, PhD; Jean-Luc Diehl, MD; Christophe Andreotti, MD;Olivier Varenne, MD, PhD; Pierre Leroux, MD; Jean-Baptiste Lascarrou, MD; Patrice Guerin, MD, PhD;Thomas Loeb, MD; Eric Roupie, MD, PhD; Cédric Daubin, MD; Farzin Beygui, MD, PhD; Florence Boissier, MD, PhD;Nicolas Marjanovic, MD, PhD; Luc Christiaens, MD, PhD; Aurélie Vilfaillot, MS; Sophie Glippa, MS;Juliette Djadi Prat, MD, PhD; Gilles Chatellier, PM, PhD; Alain Cariou, MD, PhD; Christian Spaulding, MD, PhD;for the EMERGE Investigators
Health Care Access and Management of Cardiovascular Risk Factors Among Working-Age Adults With Low Income by State Medicaid Expansion Status
Andrew S. Oseran, MD, MBA1,2; Tianyu Sun, PhD1; Rishi K. Wadhera, MD, MPP, MPhil1
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank
Kiran J. Biddinger; Sean J. Jurgens, BSc; Dimitri Maamari, MD; Liam Gaziano, MPhil; Seung Hoan Choi, PhD;Valerie N. Morrill, MS; Jennifer L. Halford, MD; Amit V. Khera, MD, MSc; Steven A. Lubitz, MD, MPH;Patrick T. Ellinor, MD, PhD; Krishna G. Aragam, MD, MS
Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality
Aniruddh P. Patel, MD; Jacqueline S. Dron, PhD; Minxian Wang, PhD; James P. Pirruccello, MD; Kenney Ng, PhD;Pradeep Natarajan, MD; Matthew Lebo, PhD; Patrick T. Ellinor, MD, PhD; Krishna G. Aragam, MD;Amit V. Khera, MD, MSc
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes
Zachary T. Yoneda, MD, MSCI; Katherine C. Anderson, ScM, CGC; Fei Ye, PhD; Joseph A. Quintana, MD; Matthew J. O’Neill, BS; Richard A. Sims, MD;Lili Sun, PhD; Andrew M. Glazer, PhD; Giovanni Davogustto, MD; Majd El-Harasis, MBBS; James L. Laws, MD; Brittany N. Saldivar, MD;Diane M. Crawford, RN; Thomas Stricker, MD, PhD; Quinn Wells, MD, PharmD, MSCI; Dawood Darbar, MBChB, MD; Gregory F. Michaud, MD;Lynne W. Stevenson, MD; Steven A. Lubitz, MD, MPH; Patrick T. Ellinor, MD, PhD; Dan M. Roden, MD; M. Benjamin Shoemaker, MD, MSCI
Trends in De Novo Hypertensive Disorders of Pregnancy Among Asian and Hispanic Population Subgroups in the United States, 2011 to 2019
Nilay S. Shah, MD, MPH; Katharine A. Harrington, MPH; Xiaoning Huang, PhD; Natalie A. Cameron, MD;Lynn M. Yee, MD, MPH; Sadiya S. Khan, MD, MSc
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019
Michael N. Young, MDStephen Kearing, MSMazen A. Albaghdadi, MD, MScAzeem Latib, MDAlexander Iribarne, MD, MS
Endurance Exercise Following Ascending Thoracic Aortic Aneurysm Resection in Bicuspid Aortic Valve Aortopathy
Andrew F. Lai, MD1; Alan C. Braverman, MD1
Athletes With Cardiovascular Disease and Competitive Sports EligibilityProgress and Challenges Ahead
Jonathan H. Kim, MD, MSc1; Neal W. Dickert, MD, PhD2
USPSTF Report on Aspirin for Primary Prevention
Donald M. Lloyd-Jones, MD, ScM1,2,3
Genetic Testing for Early-Onset Atrial Fibrillation—Is It Time to Personalize Care?
Elizabeth M. McNally, MD, PhD1,2; Sadiya S. Khan, MD, MS2,3
Improving the Detection of ST-Segment Elevation Myocardial Infarction in Rural SettingsWhen Texting Saves Lives
Uchenna R. Ofoma, MD, MS1; Karen E. Joynt Maddox, MD, MPH2
Efficacy and Safety Considerations With Dose-Reduced Direct Oral AnticoagulantsA Review
Behnood Bikdeli, MD, MS; Farbod Zahedi Tajrishi, MD; Parham Sadeghipour, MD; Azita H. Talasaz, PharmD;John Fanikos, RPH, MBA; Giuseppe Lippi, MD; Deborah M. Siegal, MD, MSc; John W. Eikelboom, MBBS;Manuel Monreal, MD, PhD; David Jimenez, MD, PhD; Jean M. Connors, MD; Walter Ageno, MD, PhD;Geoffrey D. Barnes, MD, MSc; Gregory Piazza, MD, MS; Dominick J. Angiolillo, MD, PhD; Sahil A. Parikh, MD;Ajay J. Kirtane, MD, SM; Renato D. Lopes, MD, PhD; Deepak L. Bhatt, MD, MPH; Jeffrey I. Weitz, MD;Roxana Mehran, MD; Harlan M. Krumholz, MD, SM; Samuel Z. Goldhaber, MD; Gregory Y. H. Lip, MD
Lipoprotein(a) and its Significance in Cardiovascular DiseaseA Review
Freddy Duarte Lau, MD1; Robert P. Giugliano, MD, SM2
Incidental Murmur in a Preadolescent Boy
Jordan L. W. Lam, MBBS1; Sara Saleh, MD1; Cormac O. Maher, MD1
The “Power of Zero� in Younger Patients—A Glass Half Empty or a Glass Half Full?
Pedro M. Lopes, MD1; Pedro Freitas, MD1; António M. Ferreira, MD1
The “Power of Zero� in Younger Patients—A Glass Half Empty or a Glass Half Full?—Reply
Martin Bødtker Mortensen, MD, PhD1
Macular Degeneration and CETP Inhibition
Alan R. Tall, MD1; Daniel J. Rader, MD2; John J. P. Kastelein, MD, PhD3
Macular Degeneration and CETP Inhibition—Reply
Liv Tybjærg Nordestgaard, MD, PhD1; Børge Grønne Nordestgaard, MD, DMSc2,3; Anne Tybjærg-Hansen, MD, DMSc1,3
Very Elevated High-Density Lipoprotein Cholesterol and Mortality—The Good Gone Bad?
Sadiya S. Khan, MD, MSc1,2; Gregg C. Fonarow, MD3,4
